ICU Medical price target raised to $209 from $198 at KeyBanc

KeyBanc raised the firm’s price target on ICU Medical (ICUI) to $209 from $198 on higher multiple, while keeping an Overweight rating on the shares. The firm was broadly encouraged by a continuation of improved underlying momentum, and views the initial details around its IV Solutions JV agreement favorably.